Naxions

Naxions (北京诺信创联科技) is a Beijing-based pharma digital-marketing company founded in 2015, built around the thesis that data-driven, multichannel (MCM) marketing would replace traditional drug-promotion tactics — it collects and analyzes physician behavior data to help drugmakers target and measure their marketing. FreeS Fund (峰瑞资本) met CEO 阮伟 and committed on the spot, closing an angel round in early 2016 and following on in later financings; the firm later used Naxions as a case study in network-effects SaaS, praising the founders' industry insight and data-platform capability. In July 2018 it raised a tens-of-millions-RMB A+ strategic round from IQVIA — the CRO giant's first investment inside China in over 20 years — with the two planning to link online and offline medical data into a 360-degree physician database; by mid-2020 it counted Pfizer, Bayer, Takeda, Janssen, Novo Nordisk and 20+ other top pharma companies as partners, and it raised a further $15 million in late 2019. Note that all of elsewhere's coverage of Naxions comes from its investor 峰瑞资本's own publications, and the most recent material is from 2020–2021, so its current state isn't reflected here.